New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

Neuralink, Elon Musk’s brain-computer venture, and rivals like Max Hodak’s Science, are chasing advances in technology that ...

The drug is the world’s first-ever CRISPR/Cas13 RNA-editing therapy for clinical use in treating neovascular age-related ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

If your vision is blurry or fuzzy, or if you notice that straight lines appear curved or wavy, you may have age-related ...

A new study explains not only why some patients with wet age-related macular degeneration (or 'wet' AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used ...

The Food and Drug Administration will allow a new device to be marketed as a treatment for dry age-related macular degeneration.

Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...

Have your parents or grandparents ever had trouble driving, reading or recognizing faces? They might be suffering from age-related macular degeneration, a progressive disease afflicting about 11 ...

Congress of the Asia-Pacific Vitreo-Retina Society, November 22 - 24, 2024Ophthalmology Innovation Summit XIV, November 23, 2024MELBOURNE, ...